Seagen Inc.

Federal Circuit Court of Appeals Vacates Infringement Judgment and Damages Award in Dispute between Daiichi Sankyo and Seagen

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

President Trump demands drugmakers slash prices within 60 days

Refractory Metastatic Melanoma Pipeline Report 2025, with Focus on BioNTech SE, Y-mAbs and Therapeutics Seagen

Two Brothers, a Big Biotech Bet and an $8 Billion Payout

Pfizer: Seagen Acquisition Starting To Bear Fruit

Pfizer to close Seagen manufacturing plant in Seattle area following $43B acquisition

Cramer names biopharma companies to watch as industry mergers start to pile up

5 Biotech Acquisition Targets To Accumulate In 2024

Pfizer Completes Acquisition of Seagen

Pfizer guides for US$61.5bn sales from Covid-19, Paxlovid, Seagen

8 Tax-Loss Sell Alerts For December

Pfizer to close Seagen acquisition after donating cancer drug rights

Pfizer gets OK for $43-billion Seagen deal after donating cancer drug rights

Pfizer expects to close Seagen deal on Thursday, will create a new oncology division to incorporate company

Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen

ADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy Combination Delivers 100% Progression Free Survival at 12 months in Phase 2 Trial of Patients with Early Stage Classical Hodgkin Lymphoma

TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer

Why Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?

Seagen's (SGEN) Combo Drug Expanded-Use sBLA Gets Priority Tag